Sort
11,323 grants matching “glioblastoma”
Disease Status Drug Metabolism and New Drug Discovery
$492,552Irving William Wainer · National Institute On Aging · ZIA · FY2010 · AG
Sialylation in the Maintenance and Metabolic Plasticity of Neural Stem Cell-Like Brain Tumor Cells
$492,216Anita Borton Hjelmeland · University Of Alabama At Birmingham · R01 · FY2023 · NS
Radiation-induced vascular reprogramming in glioblastoma
$492,144Harley I Kornblum · University Of California Los Angeles · R01 · FY2022 · NS
Imaging Signaling Changes in Cancer and Treatment
$492,028Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2007 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$491,992William R Roush · Scripps Florida · R01 · FY2016 · CA
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
$491,992William R Roush · Scripps Florida · R01 · FY2015 · CA
Ex vivo analysis of human brain tumor cells in a microvascular niche model
$491,875Rong Fan · Yale University · R01 · FY2024 · CA
Chemical Probes for Metabolic Pathway Discovery in Human Disease
$491,691Benjamin F Cravatt · Scripps Research Institute, The · R01 · FY2014 · CA
Calcium Channels in Glioblastoma
$491,638Roger Abounader · University Of Virginia · R01 · FY2024 · NS
Quantitative Biomarker Imaging for Early Therapy Response Assessment in Cancer
$491,577James M Mountz · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · CA
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Characterizing inhibitors of tyrosine protein kinase ABL1 (ABL1) in human glioblastoma
$491,448Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
Targeting metabolic vulnerabilities in glioblastoma
$490,971David A. Nathanson · University Of California Los Angeles · R01 · FY2020 · CA
Targeting metabolic vulnerabilities in glioblastoma
$490,971David A. Nathanson · University Of California Los Angeles · R01 · FY2021 · CA
Perivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma
$490,899Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2022 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$490,853Benjamin W. Purow · University Of Virginia · R01 · FY2017 · CA
Physical Limits of Quantitative SPECT
$490,818Brigham And Women'S Hospital · R01 · FY2002 · EB
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma
$490,666Erik Sulman · New York University School Of Medicine · R01 · FY2020 · CA
Perivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma
$490,478Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2023 · CA
Targeting the PI3K Signaling Axis
$490,407Thomas M Roberts · Massachusetts General Hospital · P50 · FY2014 · CA
MDA-7/IL-24: Therapy of Prostate Cancer
$490,383Paul B Fisher · Virginia Commonwealth University · P01 · FY2009 · CA
Pre-Clinical Trials of GEM Models for Gliomas
$490,293Sloan-Kettering Institute For Cancer Res · R01 · FY2004 · CA
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
$489,899Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)
$489,889Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2015 · CA